Are you a print subscriber? Activate your account. By Tim Nudd - 1 hour 14 min ago By Adrianne Pasquarelli - 5 hours 42 min ago By Erika Wheless - 5 hours 42 min ago By Brian Bonilla - 5 hours 42 ...

There's no guidance on drinking alcohol before getting a COVID booster or vaccine. Research on the Moderna or Pfizer-BioNTech vaccines did not ask trial participants to avoid alcohol. Research on ...

The United States on Monday said it was "deeply concerned" about a bill under consideration in Israel's parliament aimed at banning the UN's Palestinian refugee agency. "We have made quite clear ...

He went on to explain that a misconfigured component didn’t have the right “ramp up time for bringing up spin pressure” on the booster. “We were one second away from that tripping and ...

The Super Heavy booster from the fifth Starship test flight Oct. 13 returned to the launch site to be caught by the launch tower. Credit: SpaceX WASHINGTON — SpaceX’s Super Heavy booster came ...

There's some rumbling going on within Pfizer's investment community, as an activist hedge fund says that the company's performance has not been good enough. Pfizer has been in an anomalous ...

Despite that underperformance over the past 2 months, I believe Pfizer stock still deserves its "Buy" rating. In my opinion, the company is likely to exceed the third-quarter 2024 consensus ...

Proactive agents do the work ahead of time and know what to expect going into every listing appointment. Check out our comprehensive checklist, tips and scripts, plus ten key questions to ask.

This action gives people ages 18 years and older the option to receive a Novavax monovalent booster instead of an updated (bivalent) Pfizer-BioNTech or Moderna booster if they have completed ...

CVS Health is well-positioned to maintain its relevance and continue thriving in this competitive landscape. This text provides general information. Statista assumes no liability for the ...

That’s not what happened at the beginning of a recent campaign led by the hedge fund Starboard Value against pharmaceutical giant Pfizer. The FT’s Oliver Barnes, US pharmaceutical and biotech ...